| RSEYX | TEDIX | RSEYX / TEDIX | |
| Total Expense Ratio | 0.82 | 1.20 | 68% |
| Annual Report Gross Expense Ratio | 0.82 | 1.20 | 68% |
| Fund Existence | 20 years | 34 years | - |
| Gain YTD | 8.313 | 7.212 | 115% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 893M | 9.45B | 9% |
| Annual Yield % from dividends | 3.29 | 1.53 | 216% |
| Returns for 1 year | 9.13 | 8.97 | 102% |
| Returns for 3 years | 28.94 | 15.35 | 189% |
| Returns for 5 years | 20.05 | 9.47 | 212% |
| Returns for 10 years | 50.60 | 23.77 | 213% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DBOCX | 25.38 | 0.10 | +0.40% |
| BNY Mellon Balanced Opportunity C | |||
| DRRAX | 17.66 | 0.02 | +0.11% |
| BNY Mellon Global Real Return - A | |||
| VZICX | 38.38 | 0.03 | +0.08% |
| Vanguard International Core Stock Adm | |||
| PFPMX | 41.20 | -0.04 | -0.10% |
| Parnassus Mid Cap Institutional | |||
| LYFIX | 17.94 | -0.50 | -2.71% |
| AlphaCentric Life Sciences & Hlthcare I | |||